Dosing

The Emax Model in Pharmacodynamics: Understanding Dose-Response

Pharazi.ai TeamMarch 25, 20267 min read

Moving from PK to PD

PK explains what the body does to a drug. PD explains what the drug does to the body. The Emax model is the foundational bridge.

The Core Concept of Saturation

Biological targets are finite. Physiological responses are structurally saturable. Pushing higher doses past the saturation plateau yields zero additional benefit — only toxicity.

The Basic Emax Equation

E = \frac{E _{ma x} \cdot C}{E C _{50} + C}

Parameter	Meaning
$E$	Observed biological effect
$C$	Drug concentration at receptor site
$E_{ma x}$	Maximum efficacy — the absolute ceiling
$E C_{50}$	Concentration for 50% of $E_{ma x}$ — measures potency

A drug with a tiny

E C_{50}

is tremendously potent, but may have a pathetically low

E_{ma x}

(low efficacy). Clinically, efficacy always trumps potency.

The Sigmoid Hill Equation

For cooperative or allosteric receptor systems, the Hill Coefficient (

n

) upgrades the model:

E = \frac{E _{ma x} \cdot C ^{n}}{E C _{50}^{n} + C ^{n}}

Collapses to the basic Emax rectangular hyperbola. No cooperative binding.

Steep response curve. Positive cooperativity — small concentration changes rocket from zero effect to 100% maximal impact.

[!CAUTION]
$n \geq 3$ signifies a terrifyingly narrow therapeutic index. The patient pivots from unmedicated to overdose within a tiny dosing margin.

Shallow curve. Negative cooperativity or complex multi-receptor pathway.

Clinical Utility

Map the PD Target

Identify

E C_{50}

and

E_{ma x}

to set the absolute target concentration window.

Engineer the Dosing Regimen

PK team uses Clearance and Half-life to design the pill formulation and interval that holds plasma levels at the PD target.

This PK/PD fusion represents the bleeding edge of modern quantitative pharmacology.

References

Holford NH, Sheiner LB. Clin Pharmacokinet. 1981;6:429–453.
Hill AV. J Physiol. 1910;40:iv–vii.

pharmacodynamicsemax modelEC50dose-responsehill equationefficacy

All articles